factual

Does Learningrx allow a franchisee to subfranchise without written approval?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

  1. Transfer by Franchisee. Franchisee's obligations under this Addendum are personal and may not be voluntarily or involuntarily sold, pledged, assigned, transferred, shared, subdivided, sib franchised, encumbered or transferred in any way without the prior express written approval of Franchisor.

Source: Item 23 — RECEIPT (FDD pages 54–209)

What This Means (2025 FDD)

According to the 2025 Learningrx Franchise Disclosure Document, franchisees are not allowed to subfranchise without prior written approval from Learningrx. Specifically, this restriction is outlined in the context of transferring obligations related to an addendum, emphasizing that these obligations are personal and cannot be subdivided or subfranchised without express written consent from Learningrx. This requirement ensures that Learningrx maintains control over who operates Learningrx centers and upholds brand standards.

This stipulation is typical in franchising, as franchisors like Learningrx need to carefully vet and approve all operators to protect their brand and system. By requiring written approval for subfranchising, Learningrx can ensure that any potential subfranchisee meets their standards for training, financial stability, and operational expertise. This protects the integrity of the Learningrx brand and the interests of other franchisees in the system.

For a prospective Learningrx franchisee, this means they cannot delegate their operational responsibilities to another party without Learningrx's explicit permission. If a franchisee wishes to transfer their Learningrx business to someone else, they must first obtain Learningrx's approval, which Learningrx can withhold at its discretion. This provision is designed to maintain consistency and quality across all Learningrx franchise locations.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.